KIDS ORTHOPEDIATRICS CORP

Nasdaq orthopediatrics.com


$ 17.68 $ 0.17 (0.97 %)    

Tuesday, 14-Oct-2025 15:59:59 EDT
QQQ $ 598.50 $ -4.01 (-0.67 %)
DIA $ 463.08 $ 2.03 (0.44 %)
SPY $ 662.74 $ -0.81 (-0.12 %)
TLT $ 90.69 $ 0.29 (0.32 %)
GLD $ 382.95 $ 2.70 (0.71 %)
$ 17.68
$ 17.32
$ 16.33 x 100
$ 19.39 x 55
$ 17.19 - $ 18.10
$ 15.28 - $ 32.00
252,295
na
443.3M
$ 1.04
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2025 06-30-2025 10-Q
2 05-08-2025 03-31-2025 10-Q
3 03-05-2025 01-01-1970 10-K
4 11-07-2024 09-30-2024 10-Q
5 08-06-2024 06-30-2024 10-Q
6 05-07-2024 03-31-2024 10-Q
7 03-08-2024 12-31-2023 10-K
8 11-07-2023 09-30-2023 10-Q
9 08-01-2023 06-30-2023 10-Q
10 05-02-2023 03-31-2023 10-Q
11 03-01-2023 12-31-2022 10-K
12 11-01-2022 09-30-2022 10-Q
13 08-04-2022 06-30-2022 10-Q
14 05-05-2022 03-31-2022 10-Q
15 03-03-2022 12-31-2021 10-K
16 11-04-2021 09-30-2021 10-Q
17 08-05-2021 06-30-2021 10-Q
18 05-06-2021 03-31-2021 10-Q
19 03-11-2021 12-31-2020 10-K
20 11-05-2020 09-30-2020 10-Q
21 08-06-2020 06-30-2020 10-Q
22 05-06-2020 03-31-2020 10-Q
23 03-05-2020 12-31-2019 10-K
24 11-08-2019 09-30-2019 10-Q
25 08-13-2019 06-30-2019 10-Q
26 05-09-2019 03-31-2019 10-Q
27 03-07-2019 12-31-2018 10-K
28 10-31-2018 09-30-2018 10-Q
29 08-09-2018 06-30-2018 10-Q
30 05-15-2018 03-31-2018 10-Q
31 03-15-2018 12-31-2017 10-K
32 11-13-2017 09-30-2017 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 lake-street-maintains-buy-on-orthopediatrics-lowers-price-target-to-34

Lake Street analyst Ben Haynor maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and lowers the price target from $37 to $34.

 stifel-maintains-buy-on-orthopediatrics-lowers-price-target-to-20

Stifel analyst Rick Wise maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and lowers the price target from $32 to $20.

 jmp-securities-maintains-market-outperform-on-orthopediatrics-lowers-price-target-to-25

JMP Securities analyst David Turkaly maintains OrthoPediatrics (NASDAQ:KIDS) with a Market Outperform and lowers the price t...

 piper-sandler-maintains-overweight-on-orthopediatrics-lowers-price-target-to-22

Piper Sandler analyst Matt O'Brien maintains OrthoPediatrics (NASDAQ:KIDS) with a Overweight and lowers the price target...

 btig-maintains-buy-on-orthopediatrics-lowers-price-target-to-23

BTIG analyst Ryan Zimmerman maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and lowers the price target from $39 to $23.

 orthopediatrics-lowers-fy2025-sales-guidance-from-237000m-242000m-to-233500m-234500m-vs-239440m-est

OrthoPediatrics (NASDAQ:KIDS) lowers FY2025 sales outlook from $237.000 million-$242.000 million to $233.500 million-$234.500 m...

 orthopediatrics-sees-q3-sales-61200m-vs-63590m-est

OrthoPediatrics (NASDAQ:KIDS) sees Q3 sales of $61.200 million vs $63.590 million analyst estimate.

 jmp-securities-maintains-market-outperform-on-orthopediatrics-lowers-price-target-to-35

JMP Securities analyst David Turkaly maintains OrthoPediatrics (NASDAQ:KIDS) with a Market Outperform and lowers the price t...

 btig-maintains-buy-on-orthopediatrics-lowers-price-target-to-39

BTIG analyst Ryan Zimmerman maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and lowers the price target from $40 to $39.

 orthopediatrics-raises-fy2025-sales-guidance-from-23600m-24200m-to-23700m-24200m-vs-23931m-est

OrthoPediatrics (NASDAQ:KIDS) raises FY2025 sales outlook from $236.00 million-$242.00 million to $237.00 million-$242.00 milli...

 orthopediatrics-q2-adj-eps-011-beats-030-estimate-sales-6108m-miss-6140m-estimate

OrthoPediatrics (NASDAQ:KIDS) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.3...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION